507 related articles for article (PubMed ID: 17012001)
1. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series.
Conrad MF; Cambria RP; Stone DH; Brewster DC; Kwolek CJ; Watkins MT; Chung TK; LaMuraglia GM
J Vasc Surg; 2006 Oct; 44(4):762-9. PubMed ID: 17012001
[TBL] [Abstract][Full Text] [Related]
2. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease.
Conrad MF; Kang J; Cambria RP; Brewster DC; Watkins MT; Kwolek CJ; LaMuraglia GM
J Vasc Surg; 2009 Oct; 50(4):799-805.e4. PubMed ID: 19786239
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
Kudo T; Chandra FA; Ahn SS
J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
[TBL] [Abstract][Full Text] [Related]
4. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
5. The success of endovascular therapy for all TransAtlantic Society Consensus graded femoropopliteal lesions.
Han DK; Shah TR; Ellozy SH; Vouyouka AG; Marin ML; Faries PL
Ann Vasc Surg; 2011 Jan; 25(1):15-24. PubMed ID: 20932714
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
[TBL] [Abstract][Full Text] [Related]
7. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
Canaud L; Alric P; Berthet JP; Marty-Ané C; Mercier G; Branchereau P
J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions.
Costanza MJ; Queral LA; Lilly MP; Finn WR
J Vasc Surg; 2004 Feb; 39(2):343-50. PubMed ID: 14743134
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous angioplasty and stenting of the superficial femoral artery.
Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
[TBL] [Abstract][Full Text] [Related]
10. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
[TBL] [Abstract][Full Text] [Related]
11. [Femoropopliteal angioplasty: Short- and mid-term results].
Ben Hammamia M; Ben Mrad M; Derbel B; Miri R; Ziadi J; Ghedira F; Denguir R; Kalfat T
J Med Vasc; 2017 Jul; 42(4):204-212. PubMed ID: 28705338
[TBL] [Abstract][Full Text] [Related]
12. Endovascular interventions for TASC II D femoropopliteal lesions.
Baril DT; Chaer RA; Rhee RY; Makaroun MS; Marone LK
J Vasc Surg; 2010 Jun; 51(6):1406-12. PubMed ID: 20385464
[TBL] [Abstract][Full Text] [Related]
13. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
Dosluoglu HH; Cherr GS; Lall P; Harris LM; Dryjski ML
J Vasc Surg; 2008 Nov; 48(5):1166-74. PubMed ID: 18692357
[TBL] [Abstract][Full Text] [Related]
14. Primary stenting of the superficial femoral and popliteal artery.
Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience.
Kudo T; Chandra FA; Ahn SS
J Vasc Surg; 2005 Mar; 41(3):423-35; discussion 435. PubMed ID: 15838475
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions.
Baril DT; Marone LK; Kim J; Go MR; Chaer RA; Rhee RY
J Vasc Surg; 2008 Sep; 48(3):627-33. PubMed ID: 18727966
[TBL] [Abstract][Full Text] [Related]
17. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of drug-coated balloon angioplasty in patients with femoropopliteal disease: A real-world single-center experience.
AbuRahma AF; AbuRahma ZT; Scott G; Adams E; Beasley M; Davis M; Dean LS; Davis E
J Vasc Surg; 2019 Dec; 70(6):1950-1959. PubMed ID: 31401115
[TBL] [Abstract][Full Text] [Related]
19. Endovascular interventions for TransAtlantic InterSociety Consensus II C and D femoropopliteal lesions.
Yin MY; Jiang ME; Huang XT; Lu M; Lu XW; Huang Y; Li WM
Chin Med J (Engl); 2013 Feb; 126(3):415-20. PubMed ID: 23422099
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
Mohr PJ; Oyama JK; Luu JT; Stinis CT
Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
